4//SEC Filing
Reeve Emma 4
Accession 0001680329-25-000012
CIK 0001070081other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 5:20 PM ET
Size
8.6 KB
Accession
0001680329-25-000012
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Sale
Common Stock
2025-11-21$79.50/sh−10,000$795,000→ 6,666 total - Exercise/Conversion
Common Stock
2025-11-21$51.16/sh+10,000$511,600→ 16,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-21−10,000→ 0 totalExercise: $51.16Exp: 2030-01-28→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025
- [F2]Currently exercisable.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001680329
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 5:20 PM ET
- Size
- 8.6 KB